Know Your Brain: Montreal universities, institutes and research centres team up for Brain Awareness Week (BAW)
Explore your brain with the experts. Montreal neuroscientists join forces to shed light on the greyest of matters -our grey matter- during the upcoming Brain Awareness Week (March 15-21).
A new free movie series, Neuro Movie Nights, starting February 18 provides Montrealers with a unique opportunity to enjoy an alternative cinematic experience and to gain new perspectives on the mysteries and workings of the brain.
Montreal’s collective IQ will surge tomorrow (February 12, 2010) as high-school students from across the city meet to compete in the 2010 Montreal regional Brain Bee competition. This exciting challenge tests for knowledge of the brain and neuroscience. The Montreal Neurological Institute and Hospital – The Neuro, McGill University hosts the competition and graduate students from the institute ha
A new study from The Montreal Neurological Institute and Hospital – The Neuro - at McGill University is the first to discover a molecular link between Parkinson’s disease and defects in the ability of nerve cells to communicate. The study, published in the prestigious journal Molecular Cell and selected as Editor’s Choice in the prominent journal Science, provides new insight into the mechanisms u
Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.
The ability of our nervous system to function properly relies on elaborate and precise connections between nerve cells and their targets. In a new study, researchers at The Neuro - The Montreal Neurological Institute and Hospital, McGill University identify a receptor capable of directing and controlling a set of nerve cell projections to their specific target.
Dr. Brenda Milner, an active researcher at the age of 91 at the Montreal Neurological Institute, McGill University, is widely recognized as the founder of cognitive neuroscience–the field that brings together brain and behavior and helps explain key aspects of mental illness. Today, Dr. Milner is being awarded the Goldman-Rakic Prize for Outstanding Achievement in Cognitive Neuroscience by NARSAD,
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
The repair of damaged nerve cells is a major problem in medicine today. A new study by researchers at the Montreal NeurologicaI Institute and Hospital (The Neuro) and McGill University, is a significant advance towards a solution for neuronal repair.
A new study from the Montreal Neurological Institute and Hospital (The Neuro) of McGill University reveals that different patterns of training and learning lead to different types of memory formation.
World-renowned expert in immunology and genetics, Professor Sir John Bell is coming to Montreal as the guest of the Montreal Neurological Institute and Hospital (The Neuro), McGill University and the Friends of the Canadian Institutes of Health Research (CIHR).
McGill’s new Integrated Program in Neuroscience: All of McGill Neuroscience. Together in One Location.
The Integrated Program in Neuroscience (IPN) is McGill’s brand new, inter-departmental, inter-disciplinary neuroscience program for graduate students. As Canada’s largest training program for neuroscience students, this new program will bring together and encourage synergy amongst faculty members, postdoctoral fellows and students from different backgrounds all with a neuroscience focus.
Dr. Brenda Milner, the Dorothy J. Killam Professor at the Montreal Neurological Institute, McGill University, is one of four recipients of the prestigious International Balzan Prize for 2009. Each awardee will receive approximately $1 million CDN (one million swiss francs), half of which must be designated for research. The announcement was made by the Balzan Foundation Monday in Milan, Italy.